HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical experience of more than 2 months usage of extracorporeal membrane oxygenation (Endumo(®)4000) without circuit exchange.

Abstract
A 5-year-old girl with right atrial isomerism, complete atrioventricular septal defect, hypoplastic left ventricle, double outlet right ventricle, and mixed-type total anomalous pulmonary venous connection with totally occluded left pulmonary veins presented at our center for fenestrated total cavo-pulmonary connection with an extra cardiac conduit at the age of 3 years. Eleven months after the Fontan completion, she developed protein-losing enteropathy (PLE). Spontaneously closed fenestration was thought to be the cause of the PLE, and she underwent revision of fenestration at the age of 5 years. After the operation, PLE did not improve, and newly developed hypoxemia impaired her systemic ventricular function, leading to the initiation of veno-arterial extracorporeal membrane oxygenation (ECMO) with the Endumo(®) system 18 days after the operation to treat her hemodynamic instability. Although the ECMO circuit was changed three times during the first 8 days, the fourth circuit could be used for 74 days without hemolysis and serum leakage, until the patient unfortunately died 82 days after the operation due to multi-organ failure.
AuthorsKunio Kusajima, Takaya Hoashi, Koji Kagisaki, Kotaro Yoshida, Takayuki Nishigaki, Teruyuki Hayashi, Hajime Ichikawa
JournalJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs (J Artif Organs) Vol. 17 Issue 1 Pg. 99-102 (Mar 2014) ISSN: 1619-0904 [Electronic] Japan
PMID24379041 (Publication Type: Case Reports, Journal Article)
Topics
  • Child, Preschool
  • Extracorporeal Membrane Oxygenation (instrumentation)
  • Fatal Outcome
  • Female
  • Heart Defects, Congenital (complications, surgery)
  • Humans
  • Postoperative Complications (therapy)
  • Protein-Losing Enteropathies (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: